US Stock MarketDetailed Quotes

KNSA Kiniksa Pharmaceuticals International

Watchlist
  • 20.590
  • +0.100+0.49%
Close Dec 20 16:00 ET
  • 20.590
  • 0.0000.00%
Post 16:11 ET
1.49BMarket Cap-171.58P/E (TTM)

Kiniksa Pharmaceuticals International Key Stats

Kiniksa Pharmaceuticals International Q3 2024 Earnings Date

Currency:USDOct 29, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
111.60M
112.21M
+615.50K
Beat Est.
+66.45%
+67.37%
+0.55%
EPS
0.03
-0.18
-0.21
Miss Est.
+116.51%
+10.00%
-645.45%
Strong Buy

Dec 13, 2024

Kiniksa Pharmaceuticals International Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 138.406M--
--2024/Q4-- / 123.197M--
Oct 29, 20242024/Q3112.214M / 111.599M--
Jul 23, 20242024/Q2108.631M / 91.266M--
Apr 23, 20242024/Q179.858M / 78.464M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 138.406M--
--2024/Q4-- / 123.197M--
Oct 29, 20242024/Q3112.214M / 111.599M--
Jul 23, 20242024/Q2108.631M / 91.266M--
Apr 23, 20242024/Q179.858M / 78.464M--

Unlock Free Earnings Estimates

Kiniksa Pharmaceuticals International Earnings Reports

Read more

Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Analysis

Analyst Rating

Updated: Dec 13, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data